ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CGTX Cognition Therapeutics Inc

1.92
-0.07 (-3.52%)
取引時間後
最終更新日: 05:00:26
15分遅延
名称 銘柄コード 市場 種別
Cognition Therapeutics Inc CGTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.07 -3.52% 1.92 05:00:26
始値 安値 高値 終値 前日終値
1.98 1.9001 2.00 1.92 1.99
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0720:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0720:39EDGAR2Form 8-K - Current report
2024/3/1205:11EDGAR2Form 8-K - Current report
2024/3/1205:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2106:44EDGAR2Form 8-K - Current report
2024/2/2106:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1009:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2005:07EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0914:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/0906:11EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/1/0506:21EDGAR2Form 8-K - Current report
2024/1/0421:30GLOBECognition Therapeutics CEO Issues Letter to Shareholders
2023/12/3006:02EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1621:30GLOBECognition Therapeutics Releases New Episode of..
2023/11/1521:30GLOBECognition Therapeutics Presents Preclinical Data Identifying..
2023/11/1407:25EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/1323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0721:30GLOBECognition Therapeutics Completes Enrollment in Phase 2 SHINE..
2023/11/0220:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0220:41EDGAR2Form 8-K - Current report
2023/11/0220:30GLOBECognition Therapeutics Reports Third Quarter 2023 Financial..
2023/10/2720:30GLOBECognition Therapeutics and Collaborators at Yale and ACTC..
2023/10/2505:30GLOBECognition Therapeutics Presents Complete EEG Findings from..
2023/10/1620:30GLOBECognition Therapeutics Presents New Data at CTAD Conference..
2023/9/1220:00EDGAR2Form 8-K - Current report
2023/9/0720:45GLOBECognition Therapeutics Announces New Conversations Episode..
2023/8/3021:00GLOBECognition Therapeutics Announces Participation in Upcoming..
2023/8/2420:00EDGAR2Form 8-K - Current report
2023/8/0820:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:05EDGAR2Form 8-K - Current report
2023/8/0820:00GLOBECognition Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0220:30GLOBECognition Therapeutics to Report Second Quarter 2023 Results..
2023/7/1120:30GLOBECognition Therapeutics Announces Dosing of First Patient in..
2023/7/0520:30GLOBECognition Therapeutics and the Alzheimer's Clinical Trials..
2023/6/2820:00GLOBECognition Therapeutics Announces Positive Topline Results..
2023/6/2808:17GLOBECognition Therapeutics to Host Call and Webcast to Discuss..
2023/6/2020:30GLOBECognition Therapeutics Invited to Participate on Panel..
2023/6/0220:30GLOBECognition Therapeutics Continues Investor Engagement in June..
2023/5/2320:30GLOBECognition Therapeutics Latest Episode of “Conversations”..
2023/5/1820:30GLOBECognition Therapeutics Publishes Clinical Evidence that..

最近閲覧した銘柄

Delayed Upgrade Clock